Abstract
Introduction.Malassezia globosa is a yeast species that belongs to the mycobiota of humans and animals, associated with dermatological disorders, such as dandruff. This is a chronic scalp skin disorder characterized by flaking and itching. Treatments include commercial shampoo with different formulations that contain antifungal activities like zinc pyrithione (ZPT) or piroctone olamine (PO). The effectiveness of these formulations has been evaluated for decades for dandruff symptom relief of volunteers. To date, non-mammalian, in vivo methods exist to test formulations of these actives.
Aim. To evaluate in vivo in Galleria mellonella larva, two commercial antifungal shampoos (shampoo with 1 % ZPT and 1.6 % zinc Carbonate and shampoo with 0.5 % PO) against this species.
Methodology.G. mellonella larvae were inoculated with M. globosa on abraded cuticular surface. Then, integument cell viability, histological changes, and fungal burden were evaluated.
Results. Larvae inoculated with M. globosa showed higher lesion melanization and tissue damage. In addition, M. globosa population showed to increase over time. Concerning the shampoo’s effectiveness, both formulations significantly reduced M. globosa burden and tissue damage.
Conclusion.G. mellonella larvae were allowed to evaluate M. globosa superficial infection and antifungal effectiveness. Shampoos with ZPT and PO showed a positive effect on inoculated larvae.
Keywords: dandruff, Galleria mellonella, Malassezia globosa, piroctone olamine, zinc pyrithione
Data summary
All data is presented in the article and one supplementary table (S1) is available in the online version of this article. Table S1 contains the data from the MTT cell-viability assays and the fungal-burden assays carried out in this study.
Introduction
Belonging to the phylum Basidiomycota, the yeasts of the genus Malassezia are part of the commensal skin microbiota of humans and animals [1,2]. These yeasts are found mainly in areas with high sebum production due to their lipid dependence. This is due to the absence of fatty acid synthase (FAS), an enzymatic complex necessary to synthesize de novo fatty acids [3,4]. These yeasts have been associated with different systemic and dermatological entities [3]. M. globosa is one of the most frequently isolated species from healthy skin in humans [4]. However, under specific conditions, this yeast species can be associated with a causative agent of pityriasis versicolor, seborrheic dermatitis, dandruff, atopic dermatitis, and folliculitis [3,5]. The pathogenicity of Malassezia in this entity is not yet clearly known. However, it seems that the interaction of these yeasts with the host’s immune system contributes to the worsening of pre-existing symptoms [3,5].
One of the most common dermatological disorders associated with Malassezia is dandruff, characterized by scaly and itchy erythematous lesions [6,7]. This condition is often related to seborrheic dermatitis (SD) since both pathologies share symptoms, risk factors, and treatments. However, desquamation and inflammation of SD appear in areas other than the scalp (neck, face, and chest) and can be more severe. These disorders are linked to the production of lipases that hydrolyse the sebum present in the skin and lead to the release of unsaturated fatty acids and squalene peroxides that trigger the inflammatory response and increase the irritation of the stratum corneum [3,5, 6]. Around 45 % of the general population [8] suffer from (dandruff/SD). The symptoms of these skin disorders can be uncomfortable and even affect the individual’s social development, reducing their quality of life [3,5, 9].
Superficial in vitro models, such as co-culturing Malassezia spp. with keratinocytes and monocytes, skin equivalent or three-dimensional reconstructed human epidermis have been used to evaluate Malassezia–host interaction. Nevertheless, these models are limited due to the fact that they lack tissue vascularization, which would depict the occurring events better during Malassezia colonization and invasion [10]. On the other hand, among the in vivo models implemented for Malassezia are murine models, guinea pigs, canines, and rabbits [2]. These models have been inoculated directly on the skin surface using either occlusion or skin lesioning [2]. Due to their phylogenetic proximity to humans, these models make it possible to reproduce the infectious process and simulate the immune response of a human host. However, using these models is expensive and requires trained personnel, high generation times, a limited number of replicas, and approval of ethics committees [2]. Even though, these mammalian models are required to better understand the host-immune response of the complex skin environment and the associated activation of an adaptative immune response [11]. Due to this and the high prevalence of dandruff, poor knowledge of the host–pathogen interactions, and the need to evaluate commercial antifungal safety, it is important to explore additional in vivo models that allow for the determination of infection mechanisms, the virulence factors and the interaction of Malassezia with antifungals during a superficial infection.
In response to these limitations, invertebrate models, such as the Galleria mellonella larva, have been implemented to evaluate the virulence of fungal pathogens and recently to study host–Malassezia interaction during systemic infection [12]. The reasons to use this model are as follows: (1) it is easy to maintain [13], (2) it does not need to be fed through the period in which the model is used (fifth and sixth stages), (3) its wide temperatures range from 25–37 °C, which allows emulating temperatures of the mammalian organism [4,14], are economical to maintain, (5) their size facilitates their manipulation, (6) it does not require approval from an ethics committee, (7) due to its short life cycle, it allows several replicates to be made with a representative number of individuals [13,14], and (8) it has a conservated innate immune system [14].
Three ways of inoculation (injection, oral, and topical) could be used in G. mellonella [15]. Since the larval integument is composed by the cuticula, an external physical barrier, that is analogous, in function, to the stratum corneum of the skin, and an epidermal cell monolayer equivalent to the keratinocyte layer in the mammalian epidermis [16], this model may be suitable as a superficial infection model. Considering topical inoculation, a few studies have been reported, mainly filamentous fungal pathogens like Aspergillus flavus [17], dermatophytes such as Trichophyton rubrum, T. tonsurans, T. equinum, Microsporum canis, M. gypseum [18], and entomopathogens like Beauveria bassiana [19] have been tested. G. mellonella larvae have also been employed to evaluate the effects of miramistine, a topical antifungal, against Candida albicans and Aspergillus fumigatus [20].
Nevertheless, this model has not been used to evaluate the host–Malassezia interaction during superficial infections. This study aims to assess in vivo, in the standardized superficial infection model Galleria mellonella larva, two commercial antifungal shampoos against this M. globosa. The evaluated shampoo was 1 % zinc pyrithione (ZPT) 1.6 % zinc carbonate shampoo (H and S, Procter, and Gamble), and 0.5 % piroctone olamine (PO) shampoo (H and S, Procter, and Gamble). The active components of these shampoo formulations are ZPT (fungistatic) and PO (fungicidal), which are two of the most employed antifungal actives for commercial shampoo formulations [21]. To achieve this goal, G. mellonella larvae were abraded to emulate the loss of the epidermal barrier integrity proposed as an essential factor for dandruff and SD [22]. This abrasion was made based on a previous study in which sandpaper was used for this purpose [23]. After abrasion, larvae were inoculated on the cuticular surface with M. globosa, and the fungal burden, integument cell viability, and histological changes were evaluated.
Methods
Fungal strain and culture
Malassezia globosa CBS 7986 (Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands) strain was used for assays in which the infection was required. Previous to the assay, the strain was culture at 33 °C during 120 h in modified Dixon agar (mDixon agar) [36 g l−1 mycosel agar (BD, USA), 20 g l−1 Oxgall (BD, USA), 36 g l−1 malt extract (Oxoid, UK), 2 ml l−1 glycerol (Sigma Aldrich, USA), 2 ml l−1 oleic acid (Sigma Aldrich, USA), and 10 ml l−1 Tween 40 (Sigma Aldrich, USA)]. After this, a straw with a diameter of 0.4 mm was used to cut and delimit the area of the culture lawn to be inoculated.
Abrasion device
The abrasion device was designed based on a previous study [24] with modifications (Fig. 1). This device was constructed using timber to make a chamber (Fig. 1a) that supports a plate of an acrylic sheet of 2 mm as a base (dimensions); on the top of this plate, a piece of acrylic sheet of 2 mm in diameter with a notch of 2.5 mm was placed to restrain the larval movement using masking tape (Fig. 1b). This notch’s size and the acrylic sheet’s diameter allowed abrading larvae from 260 to 280 mg. The timber chamber has two rail channels on each side; in these, the structure with sandpaper (1.5×1.5 cm2) (Fig. 1c) joins the chamber, which will allow it to move across the chamber and abrade the larva as the red arrow indicates (Fig. 1d).
Fig. 1. Abrasion device. Dimension and structure of the device with instruction of the assemblage. (a) Basal chamber to anchor the abrasion system. (b) Acrylic sheet with a notch to restrain the movement of the larva. (c) Abrasion system with the sandpaper space. (d) Assembled abrasion device (discontinuos line with the red arrow indicates the movement direction of the abrasion system).
G. mellonella larvae pre-treatment
Before each assay, between 260 to 280 mg [25], larvae were weighed, stored in groups of 20 larvae in Petri plates, and incubated at 33 °C. For each assay, larvae were disinfected using a sterile cotton ball impregnated with 70 % ethanol. After this, each larva was placed into the abrasion device using masking tape to prevent larval movement. Each larva was abraded four times. Then, it was placed in a new Petri plate for the corresponding treatment [25].
Evaluation of the shampoo effect on larval tissue
Larval treatment. Groups of three larvae were put into each of the four treatment groups for this assay. The treatment groups were (1) control larvae (abraded larvae without any shampoo), (2) blank treatment (abraded larvae treated with shampoo without any antifungal active), (3) ZPT treatment (abraded larvae treated with shampoo with 1 % zinc pyrithione, 1.6 % zinc carbonate), and (4) PO treatment (abraded larvae treated with shampoo with 0.5 % piroctone olamine). Larvae belonging to the blank, ZPT, or PO treatments were treated with 3 µl of each of the corresponding shampoos, after 5 min, the shampoo was rinsed out with distilled water, and the larvae were incubated at 33 °C for 1 h or 24 h, each assay was performed in triplicate.
Tissue-damage evaluation. Modifying the tissue evaluation was followed as previously described [26,27] with modifications. Briefly, inoculated larvae and non-inoculated larvae treated with the shampoo formulations were taken to incubation for 5 min at –20 °C, then a cotton swab impregnated with 70 % ethanol was rubbed on the larval surface to eliminate M. globosa or any other cellular component that may interfere with the following cell-viability assay. The larvae were dissected to obtain a 0.25 cm2 of integument; this piece of tissue was scraped to eliminate tissue different from the integument in the presence of PBS buffer, pH 7.4. The three pieces of the dissected integument of each treatment group were put inside a well of a 48-well plate (Corning Costar) with 200 ml of [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] (MTT) (Sigma Aldrich, USA) and incubated al 37 °C during 3 h at 100 r.p.m. After this, the pieces of integument were cut for 1 min with a disposable biopsy punch (2 mm diameter) (Medline Industries, USA) in 600 r.p.m. After this, the pieces of integument were cut for 1 min with a disposable biopsy punch (2 mm diameter) (Medline Industries, USA) in 600 ml of isopropanol to dilute formazan crystals and incubated for 2 h at 25 °C at 100 r.p.m. Finally, the 100 ml of each well was taken to a new 96-well flap bottom plate (Corning Costar), and the absorbance was read at 595 nm in a Bio-Rad iMark Microplate Absorbance Reader. The cell-viability percentage was determined as follows:
In vivo evaluation of the effectiveness of shampoo against M. globosa
Larval treatment. After abrasion, using a 1 ml-inoculating loop, the surface larval abraded area was inoculated with the previously mentioned delimited area of growth of M. globosa. Then, the larvae were incubated at 33 °C for 2 h. After this period, according to the treatment group, 3 ml of each shampoo was applied to the larval dorsal surface. Then, after 5 min, the shampoo was rinsed out. The larvae were incubated at 33 °C for 1 h or 24 h. The treatment groups were as follows: (1) control larvae (abraded larvae without either M. globosa or shampoo), (2) inoculation group (abraded and inoculated larvae), (3) blank treatment (abraded and inoculated larvae treated with shampoo without any antifungal active), (4) ZPT treatment (abraded and inoculated larvae treated with shampoo with 1 % zinc pyrithione and 1.6 % zinc carbonate), and (5) PO treatment (abraded and inoculated larvae treated with shampoo with 0.5 % piroctone olamine).
Integumental fungal burden. Treated larvae were taken to −20 °C for 5 min. After this period, larvae were euthanized, and the integument of the abraded and inoculated area was put into modified Dixon broth [6 g l−1 peptone (Oxoid, UK), 20 g l−1 Oxgall (BD, USA), 36 g l−1 malt extract (Oxoid, UK), 2 ml l−1 glycerol (Sigma Aldrich, USA), 2 ml l−1 oleic acid (Sigma Aldrich, USA), and 10 ml l−1 Tween 40 (Sigma Aldrich, USA)] during 72 h at 33 °C and continuous agitation at 180 r.p.m. Then, the fragments were plated on mDixon agar and incubated for 15 days at 33 °C, recording the growth of new M. globosa colonies daily. Each treatment group was composed of three larvae and were distributed as follows: control larvae (abraded larvae without either M. globosa or shampoo), (2) inoculation group (abraded and inoculated larvae), (3) blank treatment (abraded and inoculated larvae treated with shampoo without any antifungal active), (4) ZPT treatment (abraded and inoculated larvae treated with shampoo with 1 % zinc pyrithione and 1.6 % zinc carbonate), and (5) PO treatment (abraded and inoculated larvae treated with shampoo with 0.5 % piroctone olamine). Due to the difficulty of plating and quantifying the number of c.f.u., the growth of M. globosa from plated tissue in Dixon agar was scored as one and zero if no growth was evidenced. A recovery percentage was calculated as follows:
Histology
Larvae under the different treatments and incubated for 1 h and 24 h were injected with 100 4 % paraformaldehyde in PBS buffer pH 7.4 (PFA). The larvae were kept at 4 °C for 10 days before dehydration in 70 %, 80 %, 90 % ethanol, and absolute isopropanol, followed by paraffin embedding, tissue sectioning each 5 µm, and staining with haematoxylin and eosin (H and E) [12]. The histological images were visualized under a light Leica DM500 microscope.
Statistical analysis
All experiments were performed in three independent biological replicates; the results from the cell-viability assay and the integumental fungal-burden evaluation were analysed using a two-way ANOVA test. Statistical models were constructed and analysed using GraphPad Prism 8 software (version 8.2.0). A P-value of less than 0.05 was considered to be statistically significant.
Results
Evaluation of the shampoo effect on larval tissue
To evaluate the effect of M. globosa and the antifungal actives on the integument integrity, an inoculated and treated larval cuticle was dissected, and a cell-viability assay with MTT was performed following the effective time-50 (ET-50) protocol. This protocol determines cell viability equal to or below 50 % at different periods. According to this, substances can be classified as possible corrosive, moderate irritant, moderate to mild irritant, very mild irritant, and non-irritant [26]. In this study, cell-viability assay was performed at two different periods (1) 1 h and (2) 24 h. The results showed that cell viability was significantly different for all treatments (P-value=0.0005, two-way ANOVA test), but there was no significant difference for the two periods. At the first hour of evaluation, the integument of larvae inoculated with M. globosa and treated with blank shampoo, shampoo with ZPT and PO, and without inoculation and treated with blank shampoo showed to have cell viability significantly lower concerning the control tissue (P-value<0.05, two-way ANOVA test). Evaluation at 24 h showed that cell viability of tissue inoculated with M. globosa and treated with blank shampoo or PO shampoo was significantly lower than the control tissues (P-value<0.05, two-way ANOVA test) (Fig. 2). This decrease was even higher for larvae treated with blank shampoo. Cell viability of integuments during the first hour and after 24 h were not equal or lower than 50 % for the larvae treated with the two antifungal shampoos with the antifungal actives ZPT and PO, meaning that these two shampoos cannot be classified as irritants, as it is indicated in the mentioned study [26] (Fig. 2).
Fig. 2. Cell-viability assay of the integument of larvae inoculated with M. globosa and treated with an antifungal shampoo. Control larvae were abraded but were not inoculated or treated with antifungal shampoo. Cell viability was evaluated in two different periods. A significant difference was found between treatments (P-value=0.0005, two-way ANOVA test). The fill pattern indicates inoculated and treated larvae.
Moreover, in the evaluation at the first hour of treatment, the cell viability of larvae treated with the shampoos with the antifungal actives showed to be higher than the cell viability of larvae treated with the blank shampoo. After 24 h, cell viability for cuticles treated either with the blank shampoo or the shampoos with the antifungal actives showed a slight increase. Otherwise, for larvae inoculated with M. globosa, the cell viability decreased after 24 h. A similar effect was observed in larvae inoculated with M. globosa and treated with blank shampoo. However, for the time of evaluation and the larvae inoculated with M. globosa and not treated with any of the antifungal shampoos or treated with blank shampoo, the integument of larvae treated with the two antifungal shampoos showed an increase in cell viability. This increase was even higher for tissue treated with shampoo with ZPT (Fig. 2).
In vivo evaluation of the effectiveness of shampoo against M. globosa
To determine the in vivo effectiveness of the two shampoos with the antifungal actives, larvae were inoculated with M. globosa and treated with blank shampoo and ZPT or PO. Then, integumental fungal burden was evaluated at 24, 48, and 72 h periods (Fig. 3). The fungal burden evaluation results demonstrated a significant difference (P-value<0.0001, two-way ANOVA test) in the percentage of recovery of the yeast of M. globosa between treatments. The recovery rate was higher for larvae inoculated with M. globosa and without any treatment with shampoo at any of the evaluated periods (24 h, 73 %; 48 h, 73 %; and 72 h, 80 %). This percentage of recovery was followed by the rate of recovery from the larval integument of inoculated larvae and treated with blank shampoo, which reduced the percentages of recovery to 20 % at 24 h, 19.9 % at 48 h, and 33 % at 72 h. The fungal burden of these inoculated tissues and treated with blank shampoo showed a significantly higher recovery percentage concerning control larvae (P-value=0.0035, two-way ANOVA test) and a significantly lower recovery percentage in comparison with larvae inoculated with M. globosa but without any treatment (P-value=0.0019, two-way ANOVA test). Yeast recovery from larvae treated with ZPT or shampoo with PO showed no significant difference. Also, the recovery was not different from the control larvae (P-value>0.05, two-way ANOVA test). Likewise, M. globosa recovery was significantly lower than from untreated inoculated larvae (P-value<0.0001, two-way ANOVA test). Interestingly, the fungal burden tends to increase across time but also tends to remain similar between 24 and 48 h for larvae untreated inoculated larvae, larvae treated with blank shampoo, and shampoo with ZPT. After 72 h, the fungal burden increases for the three experimental groups. Contrary to this, for larvae treated with PO, the fungal burden increases after 48 h and decreases at 72 h (Fig. 3). It is important to mention that M. globosa growth was observed only after 10 days of following up the development of c.f.u. from tissue on agar Dixon.
Fig. 3. Integumental fungal burden. The percentage of yeast recovery is calculated as previously mentioned. The fungal burden was evaluated in 24, 48, and 72 h periods. A significant difference in fungal burden between treatments was found (P-value<0.0001, two-way ANOVA test). There was a higher M. globosa recovery from untreated inoculated larvae and a lower yeast recovery from larvae treated with shampoo with PO.
Histology
To understand better the establishment and the effect of the inoculation with M. globosa and the treatment with the different shampoo formulations, the cuticle of larvae was fixed and stained with H and E. The tissues were observed under a light microscope to identify possible changes in the tissue composition and the position of M. globosa on the cuticle. One of the main changes that could observe after the abrasion is the melanization of the exocuticle in the control larvae (Fig. 4a, b). This dark pigmentation was also observed in larvae under the remaining treatments. However, the melanization was more profound in the tissue affecting the endocuticle, such as in the case of untreated inoculated larvae, larvae treated with blank shampoo, ZPT shampoo, and PO shampoo (Fig. 4c–g, i, k, l) as can be observed in Fig. 4c–f, the tissue in larvae inoculated with M. globosa and without any treatment showed higher melanized areas. These areas are consistent with the presence of the yeasts on the surface or in the endocuticle. One of the characteristics of the integument is the presence of a single layer of the epidermal cell, which can be observed in control larvae tissue.
Fig. 4. Histological evaluation of integument and macroscopical lesion images. (a)–(l) are histological assessments with H and E of integuments of the following experimental group’s (A and B) abraded control larvae. (c–f) Untreated inoculated larvae. (g) Larvae treated with blank shampoo. (h) Inoculated larvae and treated with blank shampoo. (i) Larvae treated with ZPT shampoo. (j) Inoculated larvae and treated with ZPT shampoo. (k) Larvae treated with PO shampoo. (l) Inoculated larvae and treated with PO shampoo. (m)–(q) are macroscopic images of larvae after inoculation and treatment. (m) Control larvae. (n) Untreated inoculated larvae. (o) Inoculated larvae and treated with blank shampoo. (p) Inoculated larvae and treated with ZPT shampoo. (q) Inoculated larvae and treated with PO shampoo. aa; abraded area, Ex; exocuticle, End; endocuticle; ep; epidermal layer, fb; fat bodies, Me; melanized tissue, Mg; M. globosa yeasts, and he; haemocytes.
Nonetheless, larvae infected with M. globosa present a thicker layer of cells and recruited haemocytes. This haemocyte recruitment can also be observed in larvae treated with blank shampoo (Fig. 4g) and, in part, PO shampoo (Fig. 4k). Concerning tissue integrity, the endocuticle in larvae inoculated with M. globosa is affected (Fig. 4f), and the layers of this structure start to separate. A similar change occurs in larvae inoculated with M. globosa and treated with either ZPT shampoo (Fig. 4j) or PO shampoo (Fig. 4l); the layers of the endocuticle appeared to lose their integrity but apparently in a lower proportion. Macroscopic evaluation of larvae after 24 h of treatment revealed that inoculated larvae tended to have higher melanization in the abraded area (Fig. 4n) than control larvae (Fig. 4m), M. globosa-inoculated larvae and treated with ZPT (Fig. 4p) or PO shampoo (Fig. 4q). Also, inoculated larvae treated with blank shampoo (Fig. 4o) showed darker lesion areas than larvae treated with ZPT shampoo and PO shampoo. However, contrary to inoculated larvae treated with blank shampoo, untreated inoculated larvae presented a reddish scab (Fig. 4n).
Discussion
The G. mellonella larva is an easy-to-handle model implemented as a systemic infection for M. furfur and M. pachydermatis [12]. In this study, for the first time, G. mellonella has been implemented as a superficial infection model for M. globosa to evaluate the infection and commercial antifungal shampoo effectiveness. Many studies have implemented diverse in vitro protocols to assess the efficacy of different commercial shampoo formulations against M. furfur, M. restricta, and M. globosa [21,28, 29]. Zinc pyrithione and piroctone olamine have been tested in distinct combinations. Since testing cosmetics on animals has been prohibited in many regions of the globe, in vivo evaluation of the effectiveness of anti-dandruff shampoos has relied on human studies to assess dandruff symptom relief [21]. However, assessment of the effect of the interaction of shampoos and Malassezia have not been tested in vivo, requiring in vivo models to evaluate the efficacy of products like anti-dandruff shampoos.
The integument of G. mellonella larvae has analogue structures to mammal skin, such as the layer of the cuticle (exocuticle and endocuticle) that has an analogue function with the skin stratum corneous, protecting the tissue from desiccation and epidermal cells monolayer that has a similar role to that of keratinocytes [16]. As one important risk factor for developing dandruff is the loss of skin-barrier integrity [22], in this study, larvae were abraded four times to affect the integrity of the exocuticle and to emulate the condition of skin-barrier disruption. Also, the shampoo formulation was rinsed from the larvae surface as this is the condition in which this kind of product is used. After the treatment with any of the two evaluate shampoos, the larval integument showed an increase cell viability after 24 h, which shows the low irritant potential of the two shampoos being assessed [26].
The final cell viability after 24 h of the integument of larvae inoculated and treated with PO shampoo was significantly lower concerning control larval tissue. Still, the evaluation of the effectiveness of this shampoo showed that it can control the M. globosa population on the integument. The cell viability was higher for cuticles treated with ZPT shampoo. That may be because PO has shown a lower adverse effect on Malassezia than ZPT when PO is formulated alone without salicylic acid [29]. In contrast, when PO is administrated with salicylic acid [30] or climbazole [21] it has shown a similar or higher effect to that of ZPT against Malassezia and the control of dandruff. Also, it has been demonstrated that PO treatments require more extended periods to show a higher positive effect on the scalp of patients with dandruff [21]. The observed low cell viability must be related to the enzymatic activity of lipases, phospholipase, and proteases of M. globosa. In vitro, treatment with ZPT shampoo (H and S, Procter, and Gamble) has shown that a short exposure time to the shampoo can lead to the reduction of more than 50 % of cell growth of M. globosa and almost a 100 % of reduction for M. restricta and M. furfur [28]. With respect to the blank shampoo, as has been demonstrated previously for non-anti-dandruff shampoo or detergents, these formulations do not inhibit Malassezia growth [28]. However, as observed in this study, the effect of enzymatic activity of M. globosa and the impact of this non-anti-dandruff shampoo appears to be additive. However, it is expected that with continuous use of these PO and ZPT shampoos, the M. globosa population will be lower, so the positive effect of these shampoos will be higher.
Concerning the antifungal effectiveness of both shampoo formulations, ZPT and PO shampoo showed a significant decrease in fungal burden for no treated larvae. After 72 h, the fungal burden star increases for ZPT; however, larvae treated with PO shampoo stars show a decrease in fungal burden after 72 h of incubation. In a previously published study, the substantivity of the antifungal actives PO and ZPT were evaluated, and the results showed that the substantivity of PO was higher, which means that PO could remain longer on the scalp [21], which could be the reason why the shampoo with PO is still inhibiting Malassezia growth after 72 h. Due to Malassezia’s role in maintaining skin health, it is worth highlighting the importance of maintaining an equilibrium in the yeast population, meaning that treatments should lead to controlling but not eliminating it.
Histological changes in larvae inoculated with M. globosa resembled histological changes in the stratum corneous of patients with dandruff; this includes an accumulation of epidermal cells under the lesion area, which make the integument thicker. This epidermal cell migration is part of the wound-healing process of insects [31]. Then, the epidermal cells accumulate under the cuticle, and cell layers detach from it. These alterations in integumental tissue can be reduced using either of the two shampoos’ formulations. An oppositive effect is observed in larvae treated with blank shampoo, in which tissue integrity is lost.
In conclusion, G. mellonella larva is a valuable model for studying Malassezia–host interaction during superficial interaction. Also, this model can be implemented to evaluate antifungal effectiveness. Here, ZPT and PO shampoos reduced fungal burden and displayed less tissue damage and histological changes associated with Malassezia inoculation.
supplementary material
Acknowledgements
We thank the Department of Biological Science and AnimalCore at Universidad de Los Andes for providing G. mellonella larvae.
Abbreviations
- FAS
fatty acid synthase
- MTT
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide
- PO
piroctone olamine
- SD
seborrheic dermatitis
- ZPT
zinc pyrithione
Footnotes
Funding: External funding from Procter and Gamble was received for this study.
Ethical statement: Ethical approval is not required since G. mellonella is an alternative infection model.
Author contributions: All authors contributed to this work. A.M.C.R., the corresponding author, was involved in conceptualization, funding acquisition, investigation, supervision, validation, and writing – review and editing. M.T. and J.D.O. were involved in conceptualization, data curation, formal analysis, investigation, methodology, visualization, and writing – original draft. M.G.D. and J.R.S. were involved in conceptualization, validation, and writing – review and editing.
Consent to publish: All authors agree to consent to the publication.
Contributor Information
Maritza Torres, Email: marit-to@uniandes.edu.co.
Juliana Diaz-Ortiz, Email: j.diaz15@uniandes.edu.co.
Michael G. Davis, Email: davis.mg.2@pg.com.
James R. Schwartz, Email: schwartz.jr.2@pg.com.
Adriana Marcela Celis Ramírez, Email: acelis@uniandes.edu.co.
References
- 1.Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. yeasts of emerging concern in Fungemia. Front Cell Infect Microbiol. 2020;10:370. doi: 10.3389/fcimb.2020.00370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Torres M, de Cock H, Celis Ramírez AM. In vitro or in vivo models, the next frontier for unraveling interactions between Malassezia spp. and hosts. How much do we know? J Fungi. 2020;6:155. doi: 10.3390/jof6030155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Celis A, Wösten HAB, Triana S, Restrepo S, de Cock H. Malassezia spp. beyond the mycobiota. SM Dermatolog J. 2017;3:1–10. doi: 10.36876/smdj.1019. [DOI] [Google Scholar]
- 4.Vijaya Chandra SH, Srinivas R, Dawson TL, Common JE. Cutaneous Malassezia: commensal, pathogen, or protector? Front Cell Infect Microbiol. 2020;10:614446. doi: 10.3389/fcimb.2020.614446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;10:112. doi: 10.3389/fcimb.2020.00112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Meray Y, Gençalp D, Güran M. Putting it all together to understand the role of Malassezia spp. in dandruff etiology. Mycopathologia. 2018;183:893–903. doi: 10.1007/s11046-018-0283-4. [DOI] [PubMed] [Google Scholar]
- 7.Salamanca-Córdoba MA, Zambrano-Pérez CA, Mejía-Arbeláez C, Motta A, Jiménez P, et al. Seborrheic dermatitis and its relationship with Malassezia spp. Infect. 2020;25:120. doi: 10.22354/in.v25i2.930. [DOI] [Google Scholar]
- 8.Saint Leger D. Sci Hair Care. 2nd edn. New York: Tailor Fr Boca Rat; 2005. Dandruff (pityriasis capitis simplex): of yeasts and men; pp. 609–631. [Google Scholar]
- 9.Narshana M, Ravikumar P. An overview of dandruff and novel formulations as a treatment strategy. IJPSR. 2018;9:417–431. doi: 10.13040/IJPSR.0975-8232.9(2).417-31. [DOI] [Google Scholar]
- 10.Lee Y-J, Yassa C, Park S-H, Song SW, Jung WH, et al. Interactions between Malassezia and new therapeutic agents in atopic dermatitis affecting skin barrier and inflammation in recombinant human epidermis model. Int J Mol Sci. 2023;24:6171. doi: 10.3390/ijms24076171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sparber F, De Gregorio C, Steckholzer S, Ferreira FM, Dolowschiak T, et al. The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe. 2019;25:389–403. doi: 10.1016/j.chom.2019.02.002. [DOI] [PubMed] [Google Scholar]
- 12.Torres M, Pinzón EN, Rey FM, Martinez H, Parra Giraldo CM, et al. Galleria mellonella as a novelty in vivo model of host-pathogen interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879. Front Cell Infect Microbiol. 2020;10 doi: 10.3389/fcimb.2020.00199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jemel S, Guillot J, Kallel K, Botterel F, Dannaoui E. Galleria mellonella for the evaluation of antifungal efficacy against medically important fungi, a narrative review. Microorganisms. 2020;8:390. doi: 10.3390/microorganisms8030390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pereira TC, de Barros PP, Fugisaki LR de O, Rossoni RD, Ribeiro F de C, et al. Recent advances in the use of Galleria mellonella model to study immune responses against human pathogens. J Fungi. 2018;4:128. doi: 10.3390/jof4040128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Allegra E, Titball RW, Carter J, Champion OL. Galleria mellonella larvae allow the discrimination of toxic and non-toxic chemicals. Chemosphere. 2018;198:469–472. doi: 10.1016/j.chemosphere.2018.01.175. [DOI] [PubMed] [Google Scholar]
- 16.Burra S, Wang Y, Brock AR, Galko MJ. Using Drosophila larvae to study epidermal wound closure and inflammation. Methods Mol Biol. 2013;1037:449–461. doi: 10.1007/978-1-62703-505-7_26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Scully LR, Bidochka MJ. Serial passage of the opportunistic pathogen Aspergillus flavus through an insect host yields decreased saprobic capacity. Can J Microbiol. 2005;51:185–189. doi: 10.1139/w04-124. [DOI] [PubMed] [Google Scholar]
- 18.Achterman RR, Smith AR, Oliver BG, White TC. Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model. Fungal Genet Biol. 2011;48:335–341. doi: 10.1016/j.fgb.2010.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dubovskiy IM, Whitten MMA, Kryukov VY, Yaroslavtseva ON, Grizanova EV, et al. More than a colour change: insect melanism, disease resistance and fecundity. Proc Biol Sci. 2013;280:20130584. doi: 10.1098/rspb.2013.0584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Osmanov A, Wise A, Denning DW. In vitro and in vivo efficacy of miramistin against drug-resistant fungi. J Med Microbiol. 2019;68:1047–1052. doi: 10.1099/jmm.0.001007. [DOI] [PubMed] [Google Scholar]
- 21.Schmidt-Rose T, Braren S, Fölster H, Hillemann T, Oltrogge B, et al. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci. 2011;33:276–282. doi: 10.1111/j.1468-2494.2010.00623.x. [DOI] [PubMed] [Google Scholar]
- 22.Limbu SL, Purba TS, Harries M, Wikramanayake TC, Miteva M, et al. A folliculocentric perspective of dandruff pathogenesis: could a troublesome condition be caused by changes to a natural secretory mechanism? Bioessays. 2021;43:e2100005. doi: 10.1002/bies.202100005. [DOI] [PubMed] [Google Scholar]
- 23.Brey PT, Lee WJ, Yamakawa M, Koizumi Y, Perrot S, et al. Role of the integument in insect immunity: epicuticular abrasion and induction of cecropin synthesis in cuticular epithelial cells. Proc Natl Acad Sci U S A. 1993;90:6275–6279. doi: 10.1073/pnas.90.13.6275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Fredericks LR, Lee MD, Roslund CR, Crabtree AM, Allen PB, et al. The design and implementation of restraint devices for the injection of pathogenic microorganisms into Galleria mellonella. PLoS One. 2020;15:e0230767. doi: 10.1371/journal.pone.0230767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Diaz Ortiz J. Galleria mellonella as an in vivo skin model of superficial infections caused by Malassezia globosa. Universidad de los Andes. 2021 [Google Scholar]
- 26.Kose O, Erkekoglu P, Sabuncuoglu S, Kocer-Gumusel B. Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model. Regul Toxicol Pharmacol. 2018;98:268–273. doi: 10.1016/j.yrtph.2018.08.010. [DOI] [PubMed] [Google Scholar]
- 27.Erickson-DiRenzo E, Sivasankar MP, Thibeault SL. Utility of cell viability assays for use with ex vivo vocal fold epithelial tissue. Laryngoscope. 2015;125:E180–E185. doi: 10.1002/lary.25100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Leong C, Schmid B, Buttafuoco A, Glatz M, Bosshard PP. In vitro efficacy of antifungal agents alone and in shampoo formulation against dandruff-associated Malassezia spp. and Staphylococcus spp. Int J Cosmet Sci. 2019;41:221–227. doi: 10.1111/ics.12525. [DOI] [PubMed] [Google Scholar]
- 29.dos Santos RM, Dias-Souza MV. Effectiveness of five antidandruff cosmetic formulations against planktonic cells and biofilms of dermatophytes. Saudi J Biol Sci. 2017;24:331–337. doi: 10.1016/j.sjbs.2015.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lodén M, Wessman C. The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo. Int J Cosmet Sci. 2000;22:285–289. doi: 10.1046/j.1467-2494.2000.00024.x. [DOI] [PubMed] [Google Scholar]
- 31.Galko MJ, Krasnow MA. Cellular and genetic analysis of wound healing in Drosophila larvae. PLoS Biol. 2004;2:E239. doi: 10.1371/journal.pbio.0020239. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




